Efficacy and Tolerance of Cetuximab Alone or Combined with Chemotherapy in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: An Open Study of 14 Patients.

about

Efficacy and Tolerance of Cetuximab Alone or Combined with Chemotherapy in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: An Open Study of 14 Patients.

Item

http://www.wikidata.org/entity/Q51068718

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Efficacy and Tolerance of Cetu ...... An Open Study of 14 Patients.

@en

Efficacy and Tolerance of Cetu ...... An Open Study of 14 Patients.

@nl

type

Item

label

Efficacy and Tolerance of Cetu ...... An Open Study of 14 Patients.

@en

Efficacy and Tolerance of Cetu ...... An Open Study of 14 Patients.

@nl

prefLabel

Efficacy and Tolerance of Cetu ...... An Open Study of 14 Patients.

@en

Efficacy and Tolerance of Cetu ...... An Open Study of 14 Patients.

@nl

P1476

Efficacy and Tolerance of Cetu ...... An Open Study of 14 Patients.

@en

P2093

Bernard Guillot

http://www.w3.org/2001/XMLSchema#string

Céline Girard

http://www.w3.org/2001/XMLSchema#string

Hamoudeh Missan

http://www.w3.org/2001/XMLSchema#string

Olivier Dereure

http://www.w3.org/2001/XMLSchema#string

Valérie Costes

http://www.w3.org/2001/XMLSchema#string

P2860

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report.

Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.

Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp.

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study.

Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancer.

Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis.

Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer.

Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer

Combination of docetaxel and cetuximab for penile cancer: a case report and literature review.

Treatment of advanced cutaneous squamous cell carcinomas with epidermal growth factor receptor inhibitors.

P304

721-730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000461578

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

232

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28384639

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab